Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Study of a Hypertensive Population Under Treatment With Micardis® and Micardis Plus® Under Real Clinical Conditions With the Goal to Control the Early Morning BP Rise (SURGE II)

NCT02242396 is registered in ClinicalTrials.gov with Boehringer Ingelheim as lead sponsor.

NCT NCT02242396
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02242396 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Study of a Hypertensive Population Under Treatment With Micardis® and Micardis Plus® Under Real Clinical Conditions With the Goal to Control the Early Morning BP Rise (SURGE II)
Lead sponsor
Boehringer Ingelheim
Phase
Observational
Overall status
Completed
Start date
August 31, 2005
Completion date
Not reported
Enrollment
5,248 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

hypertension